Shots:
Biopharma companies have kept themselves afloat in the ocean of uncertainties by overcoming the hurdles of unmet demands, procurement, and maintaining a constant supply chain. However, the previous year was difficult for biopharma companies as the segment saw multiple insolvencies.
Amidst all kinds of obstacles, many companies have sustained themselves to meet the market…
TOP 20
Shots:
Drug patent expiry is when a patent granted to a pharmaceutical company for a particular drug expires, allowing other companies to produce and sell generic versions
Like every other utility patent, pharmaceuticals also get market exclusivity of 20 years. Some companies accept the offered period and open doors to biological drugs or biosimilars. In…
Shots:
Post M&A deals, companies often cannot sail through a few key aspects of the partnership, such as limited ownership, exorbitant recovery costs, and poor integration process, leading to deal terminations. The improperly executed expansion program also contributes significantly to the failed partnership
To tackle such scenarios, companies are cautious enough to make backup plans beforehand…
Shots:
Trailblazing, inspiring, and emancipating, women’s contribution to society is highly significant. By breaking the shackles of orthodox social customs, they made an indistinguishable place in society that we all should be proud of
Every year on the 8th of March, the world celebrates International Women’s Day as a day of observance for women’s triumph in the social,…
Shots:
Integrating scintigraphy with therapeutics, radiopharmaceutical companies have emerged profoundly in the past few decades. With the growing influence of radiopharmaceutical companies in oncology, the companies hold a firm grasp on the market
With the expanding acceptance among HCPs, patients, and researchers, radiopharmaceutical companies are estimated to touch the $7.5B threshold by 2026. This year,…
Shots:
The technological advancement, shared cost, and the pursuit of combined extensive research are amongst the few pragmatic and mutual benefits that come with collaborations. Moreover, the risks involved in drug development plans get minimalized by opening the doors to new opportunities and commercialization
When it comes to life science collaborations, companies seek beyond the…
Shots:
Immutable capital demands and high-spending drug development plans are the most common drivers in encouraging fully-fledged private healthcare companies to go public. Apart from the exposure and capital raise, companies gain more recognition, credibility, and indispensable value assessment
2022 had been a great year when it comes to the IPOs of healthcare companies. Bausch…
Shots:
Mergers and Acquisitions are among the predominant elements of the Biopharma Industry. Owing to the repercussions of the Russia-Ukraine war and the ongoing COVID-19 pandemic, the IPOs, public markets, anti-trust law reforms by the US FTC, and M&As among others were relatively low in the biopharma sector in the year 2022
In the year…
Shots:
The Animal Health industry plays a vital role in safeguarding animal husbandry and has experienced an evolving change over the years from disease control and treatment activities to a complete healthcare provider
As the bond between owners and their animal companion strengthens, the Animal Health industry foresees an exponential growth in the near future.…
Shots:
The pharmaceutical companies have shown continual efforts towards developing enhanced and innovative treatment options to address the unmet needs of patients with disease eradication being the goal of developing these treatments
Advancements in cellular and molecular biology have increased the possibilities for generating new pharmaceutical products imposing major impacts on the prevention, diagnosis, and…

